Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Isoproterenol Hydrochloride

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 112,959Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Somerset's Generics Isoproterenol HCl Receives Approval in US
    Somerset's Generics Isoproterenol HCl Receives Approval in US

    06 Aug 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211590

    FDA
    06 Aug 2024
    Share Share
    Avenacy Launches Isoproterenol Hydrochloride Injection In US
    Avenacy Launches Isoproterenol Hydrochloride Injection In US

    20 May 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240520809549/en

    BUSINESSWIRE
    20 May 2024
    Share Share
    AM's Generic Isoproterenol Hydrochloride Receives Approval in the U.S.
    AM's Generic Isoproterenol Hydrochloride Receives Approval in the U.S.

    19 Oct 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214775

    FDA
    19 Oct 2022
    Share Share
    STI's Generic Isoproterenol Hydrochloride Receives Approval in the U.S.
    STI's Generic Isoproterenol Hydrochloride Receives Approval in the U.S.

    20 Sep 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215542

    FDA
    20 Sep 2022
    Share Share
    Mylan's Generic Isoproterenol Hydrochloride Receives Approval in the U.S.
    Mylan's Generic Isoproterenol Hydrochloride Receives Approval in the U.S.

    06 Sep 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212573

    FDA
    06 Sep 2022
    Share Share
    Avet's Generic Isoproterenol Hydrochloride Receives Approval in the US
    Avet's Generic Isoproterenol Hydrochloride Receives Approval in the US

    19 Nov 2021

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212189

    FDA
    19 Nov 2021
    Share Share